scispace - formally typeset
H

Herman A. Taylor

Researcher at Morehouse School of Medicine

Publications -  301
Citations -  22952

Herman A. Taylor is an academic researcher from Morehouse School of Medicine. The author has contributed to research in topics: Population & Genome-wide association study. The author has an hindex of 67, co-authored 279 publications receiving 19905 citations. Previous affiliations of Herman A. Taylor include University of Mississippi & Johns Hopkins University.

Papers
More filters
Journal ArticleDOI

Biological, clinical and population relevance of 95 loci for blood lipids

Tanya M. Teslovich, +218 more
- 05 Aug 2010 - 
TL;DR: The results identify several novel loci associated with plasma lipids that are also associated with CAD and provide the foundation to develop a broader biological understanding of lipoprotein metabolism and to identify new therapeutic opportunities for the prevention of CAD.
Journal ArticleDOI

The genetic architecture of type 2 diabetes

Christian Fuchsberger, +349 more
- 11 Jul 2016 - 
TL;DR: In this paper, the authors performed whole-genome sequencing in 2,657 European individuals with and without diabetes, and exome sequencing for 12,940 individuals from five ancestry groups.

The genetic architecture of type 2 diabetes

Christian Fuchsberger, +300 more
TL;DR: Large-scale sequencing does not support the idea that lower-frequency variants have a major role in predisposition to type 2 diabetes, but most fell within regions previously identified by genome-wide association studies.
Journal ArticleDOI

Cardiovascular Health in African Americans: A Scientific Statement From the American Heart Association

TL;DR: The higher prevalence of traditional cardiovascular risk factors underlies the relatively earlier age of onset of cardiovascular diseases among African Americans and contributes directly to the notable disparities in stroke, heart failure, and peripheral artery disease among African American.
Journal ArticleDOI

Socioeconomic Status and Cardiovascular Outcomes: Challenges and Interventions.

TL;DR: The current state of knowledge on the impact of SES on the incidence, treatment, and outcomes of CVD in high-income societies is reviewed and future research directions aimed at the elimination of these adverse factors, and the integration of measures of S ES into the customization of cardiovascular treatment are suggested.